RivaXa 10
- RivaXa: Available in 2.5 mg and 10-20 mg doses.
- Prevents Atherothrombotic Events: Post-Acute Coronary Syndrome (ACS).
- Reduces Risk of Stroke and Systemic Embolism: Especially in nonvalvular atrial fibrillation.
- Highly Selective Factor Xa Inhibitor: Efficiently disrupts blood coagulation pathways.
- Manages DVT and PE: Provides effective treatment and prevention strategies.
- Careful Dosage Guidance: Ensures patient safety and well-being.